LevelJump Closes $900,000 Private Placement
LevelJump Closes $900,000 Private Placement
Toronto, Ontario--(Newsfile Corp. - June 15, 2023) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that, following receipt of TSXV approval, it has sold and closed the sale of 7,200,000 Units (each a "Unit") to an accredited investor at a subscription price of $0.125 per Unit for gross proceeds of $900,000.
安大略省多倫多--(Newsfile Corp.-2023年06月15日)-加拿大B2B遠端醫療解決方案領先企業LevelJump Healthcare Corp.(多倫多證券交易所股票代碼:JUMP)(場外交易市場代碼:JMPHF)(證券交易所股票代碼:75J)(以下簡稱“LevelJump”或“公司”)欣然宣佈,在獲得多倫多證券交易所的批准後,該公司已向一家經認可的投資者出售並完成了7,200,000個單位(每個單位為“單位”)的銷售,認購價為每單位0.125美元,總收益為900,000美元。
Each Unit consists of one common share ("Common Share"), and one common share purchase warrant ("Warrant"), with each Warrant entitling the holder to purchase one common share in the capital of the Company at an exercise price of $0.20 per common share for a period of 24 months from the date of issuance.
每個單位包括一股普通股(“普通股”)和一份普通股認購權證(“認股權證”),每份認股權證使持有人有權按每股普通股0.20美元的行使價購買一股公司股本中的普通股,自發行之日起為期24個月。
The proceeds raised from the issuance of the Units are intended to be used for the Company's Alberta acquisition (see the Company's news releases dated November 16, 2022, and March 6, 2023) and for general working capital. The Company has paid a finder's fee of $63,000 to certain finders in conjunction with this placement. All securities issued in connection with this placement will be subject to a statutory hold period of four months and one from the closing date.
發行這些單位所得款項將用於公司在艾伯塔省的收購(見公司於2022年11月16日和2023年3月6日發佈的新聞稿)和一般營運資金。該公司已就此次配售向某些發現者支付了63,000美元的發起人費用。與是次配售有關而發行的所有證券,將受四個月及由截止日期起計一個月的法定持有期所規限。
Early Warning Disclosure
預警資訊披露
Nadia Abdul Aziz and Malik M Easah (the "Acquiror") makes the following announcement in accordance with National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and National Instrument 62-104 Take-Over Bids and Issuer Bids.
納迪亞·阿卜杜勒·阿齊茲和馬利克·M·伊薩(The收購心理“)根據《國家文書62-103》發佈如下公告預警系統及相關收購競標和內幕報告問題和國家儀器62-104接管投標和發行人投標。
Pursuant to the closing of the placement, the Company issued to the Acquiror, and the Acquiror purchased from the Company 7,200,000 Units at a price of $0.125 per Unit for a purchase price of $900,000 in reliance on the prospectus exemption contained in section 2.10 of National Instrument 45-106 Prospectus Exemption (the "Acquisition").
於配售完成後,本公司向收購方發行7,200,000個單位,收購方以每單位0.125美元的價格向收購方購買7,200,000個單位,收購價格為900,000美元,依據國家檔案45-106招股說明書豁免第2.10節(“招股章程豁免”)。採辦“)。
Immediately prior to the Acquisition, the Acquiror beneficially owned and had control and direction over 1,450,000 Shares and 1,000,000 Warrants representing approximately 1.7% (2.8% on a partially diluted basis) of the then issued and outstanding shares. As a result of the Acquisition, the Acquiror beneficially owns and has control and direction over 8,650,000 Shares and 8,200,000 Warrants, representing approximately 9.2% (16.4% on a partially diluted basis) of the issued and outstanding Shares of the Company after closing of the Offering. The change in the Acquiror's security holding percentage is 7.5% (13.6% on a partially diluted basis) of the issued and outstanding Shares.
緊接收購前,收購人實益擁有及控制及指揮1,450,000股股份及1,000,000份認股權證,佔當時已發行及已發行股份約1.7%(按部分攤薄後計算為2.8%)。收購事項的結果是,收購方實益擁有8,650,000股股份及8,200,000份認股權證,並對其擁有控制權及指揮權,相當於發售完成後本公司已發行及已發行股份約9.2%(按部分攤薄基準計算為16.4%)。收購方證券持有比例的變化為已發行和已發行股票的7.5%(部分稀釋後為13.6%)。
The Acquiror acquired the Units for investment purposes. The Acquiror will review its holdings from time to time and may, in the future, increase or decrease his ownership or control over securities of the Company as circumstances dictate.
收購人出於投資目的收購了這些單位。收購方將不時審查其所持股份,並可能在未來根據情況增加或減少其對本公司證券的持有量或控制權。
An early warning report will be filed under the Company's profile on the SEDAR website at .
一份預警報告將在SEDAR網站上的公司簡介下提交。
About LevelJump Healthcare
關於LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its IHF's (Independent Healthcare Facilities). JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
LevelJump Healthcare Corp.(多倫多證券交易所股票代碼:JUMP)通過其遠端放射部門為客戶醫院和成像中心提供遠端醫療解決方案,並通過其IHF(獨立醫療設施)提供面對面的放射服務。JUMP主要專注於緊急和緊急患者的危重護理,在我們所服務的社區中建立完整的關係。
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
我謹代表華為的董事會
LEVELJUMP醫療保健公司。
Mitchell Geisler
Chief Executive Officer
米切爾·蓋斯勒
首席執行官
Caitlin-Robyn Densmore
Investor Relations Manager
Caitlin.Densmore@leveljumphealthcare.com
(437) 214-1568
凱特琳-羅賓·丹斯莫爾
投資者關係經理
郵箱:Caitlin.Densmore@Levjumphelthare.com
(437)214-1568
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
關於前瞻性資訊的警示聲明
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
本新聞稿包含與公司業務計劃和公司行業前景相關的適用證券法所指的“前瞻性資訊”。儘管本公司認為,根據其高級管理人員和董事的經驗、當前狀況和預期未來發展以及其他被認為合適的因素,這些前瞻性資訊中反映的預期是合理的,但不應過度依賴這些預期,因為本公司不能保證這些預期將被證明是正確的。實際結果和發展可能與這些陳述中預期的大不相同。本新聞稿中的陳述是截至本新聞稿發佈之日作出的,公司不承擔任何責任對其進行更新或修改,以反映除適用證券法所要求的以外的新事件或新情況。本公司沒有義務對第三方對本公司、加拿大TelerRadiology Services,Inc.、其證券或其各自的財務或經營業績(如適用)所作的分析、預期或陳述發表評論。
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
交易所及其監管服務提供商(該術語在交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
所發行的證券尚未、也不會根據修訂後的《1933年美國證券法》(下稱《美國證券法》)或美國任何州證券法進行註冊,在未進行註冊或未獲得美國證券法和適用的美國州證券法的註冊要求豁免的情況下,不得在美國境內或向美國人、為美國個人或為美國人的利益進行發行或銷售。本新聞稿不構成在美國或其他任何司法管轄區出售證券的要約或購買證券的要約。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問